Gene expression of hENT1, dCK, CDA, dCMPD and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin.

Cancer Manag Res · 2018 · PMC6235003 · PMID 30519105

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although bone marrow Topo-IIa showed a trend of being higher among good responders, it did not reach significance.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Bone marrow Topo-IIa expression followed a similar trend but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Gene expression of <i>hENT1</i>, <i>dCK</i>, <i>CDA</i>, <i>dCMPD</i> and topoisomerase IIα as an indicator of chemotherapy response in AML treated with cytarabine and daunorubicin.

The sentences